Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
MAGEA3 is a member of the MAGEA gene family. Zusätzlich bieten wir Ihnen MAGEA3 Proteine (10) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 79 products:
Human Polyclonal MAGEA3 Primary Antibody für FACS, IHC (p) - ABIN390107
Guo, Wen, Huang, Paul, Wünsch, Itakura, Cochran: Detection of multiple melanoma-associated markers in melanoma cell lines by RT in situ PCR. in Experimental and molecular pathology 2003
Show all 7 Pubmed References
Human Monoclonal MAGEA3 Primary Antibody für ELISA, WB - ABIN561731
Akiyama, Oshita, Kume, Iizuka, Miyata, Komiyama, Ashizawa, Yagoto, Abe, Mitsuya, Watanabe, Sugino, Yamaguchi, Nakasu: ?-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial. in BMC cancer 2013
Human Polyclonal MAGEA3 Primary Antibody für IHC, IHC (p) - ABIN4890850
Abad, Wieërs, Colau, Wildmann, Delair, Dhote, Brézin, Kawakami, Coulie, van der Bruggen: Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient. in Molecular vision 2014
Human Polyclonal MAGEA3 Primary Antibody für EIA, IHC (p) - ABIN303466
Yin, Zeng, Wang, Liu, Zhang, Song: Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma. in International journal of clinical and experimental pathology 2014
the objective response rate was lower in this study than in other studies carried out in the same setting with the MAGE-A3 immunotherapeutic. Investigation of a gene signatures (GS) to predict clinical benefit to adjuvant MAGE-A3 immunotherapeutic treatment is ongoing in another melanoma study.
Administering autologous CD4 (zeige CD4 Antikörper)(+) T cells that are genetically engineered to express an MHC class II (zeige HLA-DPA1 Antikörper)-restricted antitumor TCR that targets MAGE-A3 can be used safely in the treatment of metastatic neoplasms.
Data show that overall survival (OS) was significantly lower for patients expressing pan (zeige SUPT6H Antikörper)-MAGE (zeige MAGEB10 Antikörper) or MAGE (zeige MAGEB10 Antikörper)-A1/A3/A4 in both independent cohorts.
These data demonstrate that MAGE (zeige MAGEB10 Antikörper)-A1-, MAGE-A3-, and NY-ESO-1 (zeige CTAG1B Antikörper)-specific T cells with antigen-specific cytotoxicity can be cultured from healthy donors and patient-derived cells making adoptive immunotherapy with these cytotoxic T lymphocyte feasible.
MAGEA3 may be demethylated in MPNST and plexiform type neurofibroma in NF-1 (zeige NF1 Antikörper) patients
MAGEA3 was overexpressed in colorectal cancer tissue compared with healthy colon. MAGEA3 expression positively correlated with colorectal cancer progression.
Comparing the overall expression of CTAs, a decreased expression of all melanoma-associated (zeige ZNF654 Antikörper) antigens (MAGEs) post-treatment and a slightly increased expression of New York esophageal squamous cell carcinoma 1 (NY-ESO-1 (zeige CTAG1B Antikörper)) was visible. The simultaneous cytoplasmic and nuclear expression of pan (zeige SUPT6H Antikörper)-MAGE (zeige MAGEB10 Antikörper) or MAGE-A3/A4 correlated with reduced treatment-failure-free-survival (TFFS).
MAGE-A3 expression is regulated epigenetically by promoter methylation, and that its expression contributes to gastric cell proliferation and drug sensitivity.
Progression free survival and levels of MAGE-A3 expression in non-small cell lung carcinoma patients with the three modes of acquired resistance are negatively correlated.
the crystal structures of MAGE-A3 and MAGE-A4 (zeige MAGEA4 Antikörper)
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita.
melanoma antigen family A, 3
, MAGE-3 antigen
, antigen MZ2-D
, cancer/testis antigen 1.3
, cancer/testis antigen family 1, member 3
, melanoma-associated antigen 3